Guardian Pharmacy Services, Inc. (GRDN) is a publicly traded Healthcare sector company. As of May 21, 2026, GRDN trades at $37.67 with a market cap of $2.27B and a P/E ratio of 0.00. GRDN moved +3.53% today. Year to date, GRDN is +20.69%; over the trailing twelve months it is +42.00%. Its 52-week range spans $15.52 to $41.36. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces GRDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns GRDN stock?
Hedge funds tracked by Rallies that own GRDN include Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Guardian Pharmacy Services, Inc..
GRDN Key Metrics
Key financial metrics for GRDN
Metric
Value
Price
$37.67
Market Cap
$2.27B
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$41.36
52-Week Low
$15.52
Volume
103
Avg Volume
0
Revenue (TTM)
$1.46B
Net Income
$53.23M
Gross Margin
20.93%
Top Hedge Funds Holding GRDN
Mangrove Partners holds 13.25K shares of GRDN, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own GRDN include Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Guardian Pharmacy Services, Inc..
Does Rallies show 13F holders for GRDN?
Yes. Rallies tracks hedge fund and 13F ownership data for GRDN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GRDN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRDN. It does not provide personalized investment advice.
